Search

Author/Creator Altay, Lebriz

2. Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials. Issue 10326 (19th February 2022)

Authors:
Heier, Jeffrey S; Khanani, Arshad M; Quezada Ruiz, Carlos; Basu, Karen; Ferrone, Philip J; Brittain, Christopher; Figueroa, Marta S; Lin, Hugh; Holz, Frank G; Patel, Vaibhavi; Lai, Timothy Y Y; Silverman, David; Regillo, Carl; Swaminathan, Balakumar; Viola, Francesco; Cheung, Chui Ming Gemmy; Won...
Journal:
Lancet
Issue:
Volume 399:Issue 10326(2022)
Page Start:
729
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Genetic screening for macular dystrophies in patients clinically diagnosed with dry age‐related macular degeneration. Issue 6 (15th October 2018)

Authors:
Kersten, Eveline; Geerlings, Maartje J.; Pauper, Marc; Corominas, Jordi; Bakker, Bjorn; Altay, Lebriz; Fauser, Sascha; de Jong, Eiko K.; Hoyng, Carel B.; den Hollander, Anneke I.
Journal:
Clinical genetics
Issue:
Volume 94:Issue 6(2018)
Page Start:
569
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗